Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Al-Tamari HM, Dabral S, Schmall A, Sarvari P, Ruppert C, Paik J, et al. FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis. EMBO Mol Med. 2018;10(2):276-293.

La Corte E, Younus I, Pivari F, Selimi A, Ottenhausen M, Forbes JA, et al. BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series. Pituitary. 2018;21(6):571-583.

Reich-Slotky R, Cushing MM, Hsu Y-, Ancharski M, Rojas JM, Scrimenti LM, et al. Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience. Transfusion. 2018;58(2):339-344.

Nellis ME, Karam O, Mauer E, Cushing MM, Davis PJ, Steiner ME, et al. Platelet Transfusion Practices in Critically Ill Children. Crit Care Med. 2018;46(8):1309-1317.

Sailer V, Schiffman MH, Kossai M, Cyrta J, Beg S, Sullivan B, et al. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2018;124(5):1008-1015.

Baker TM, Rogers W, Chavda KD, Westblade LF, Jenkins SG, Nicolau DP, et al. Epidemiology of Bloodstream Infections Caused by and That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible. Open Forum Infect Dis. 2018;5(12):ofy300.

Gafeer MM, Mohammed KH, Ormenisan-Gherasim C, Choudhary F, Siddiqui MT, Cohen C. Diagnostic Utility of PD-L1 Expression in Lung Adenocarcinoma: Immunohistochemistry and RNA In Situ Hybridization. Appl Immunohistochem Mol Morphol. 2018;26(8):e86-e90.

de Brot S, Robinson BD, Scase T, Grau-Roma L, Wilkinson E, Boorjian SA, et al. The dog as an animal model for bladder and urethral urothelial carcinoma: Comparative epidemiology and histology. Oncol Lett. 2018;16(2):1641-1649.

Truong TH, Hu H, Temiz NA, Hagen KM, Girard BJ, Brady NJ, et al. Cancer Stem Cell Phenotypes in ER Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes. Mol Cancer Res. 2018;16(4):707-719.

Tabbo F, Nottegar A, Guerrera F, Migliore E, Luchini C, Maletta F, et al. Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma. Hum Pathol. 2018;75:167-178.